Clinical Trials
3 trialsNCT06466798 2026-01-08
Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies
The University of Texas Health Science Center, Houston
Phase 1 Withdrawn
NCT03572530 2025-04-08
5-AZA
The University of Texas Health Science Center, Houston
Phase 1 Completed
NCT03206021 2024-04-05
COZMOS
The Hospital for Sick Children
Phase 1 Completed